MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202517049937 A) filed by Zevra Denmark A/S, Copenhagen, Denmark, on May 23, for 'arimoclomol compositions for use in treating niemann pick disease type c (npc).'
Inventor(s) include Pederson, Mette Lund; and Ingemann, Linda.
The application for the patent was published on June 20, under issue no. 25/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a pharmaceutical composition or formulation of arimoclomol citrate, either in monotherapy or in combination treatment therapy with miglustat, for use in one or more methods of treating Niemann Pick disease, type C (NPC) in a human patient. The present invention additionally relates arimoclomol for use in methods of treating NPC in a human patient, via dispersion or suspension of a pharmaceutical composition comprising a formulation of arimoclomol, specifically arimoclomol citrate, in at least one liquid or at least one solid medium prior to administration to the patient. The present disclosure also relates to the biomarkers and metabolites of arimoclomol."
The patent application was internationally filed on Oct. 27, 2023, under International application No.PCT/IB2023/060866.
Disclaimer: Curated by HT Syndication.
